As Pfizer continues its attempts for a takeover of AstraZeneca (LSE: AZN) (NYSE: AZN.US), Motley Fool managing director Jill Ralph and senior analyst Nate Weisshaar discuss what might be best for shareholders in the British pharmaceutical firm…
What Should You Do With Your AstraZeneca plc Shares?
VIDEO: Two Fools put AstraZeneca plc (LON:AZN) under the spotlight.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.